2nd PPRI Conference - Programme

Day 1: Thursday 29th September 2011 (09:00 – 19:00)

8:00 – 9:00 Registration and coffee (at the Aula)

Morning session 09:00 – 12:00

09:00 – 09:30    Welcome

  • Austrian Ministry of Health (BMG), Minister Alois Stöger
  • Austrian Health Institute (GÖG), General Manager Georg Ziniel
  • Austrian Health Institute (GÖG), Head of the WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Sabine Vogler
  • World Health Organization Regional Office for Europe, Regional Adviser Health, Technology and Pharmaceuticals, Kees de Joncheere

09:30 – 10:30    Pharmaceutical policies in a changing world – key statements from players in pharmaceutical systems

Chair: Hans Hogerzeil

  • Kees de Joncheere, World Health Organization Regional Office for Europe
  • Regina Skavron, Medicines Department, German Federal Joint Committee (Gemeinsamer Bundesausschuss)
  • Richard Bergström, Director General of the European Federation of Pharmaceutical Industries (EFPIA) and Head of the Swedish Association of the Pharmaceutical Industry (LIF)
  • Elizabeth Docteur, Elizabeth Docteur Consulting, USA

10:30 – 11:00    Coffee break (at the Aula)

11:00 – 12:00    Key note presentation – Solidarity and innovation

Erik Schokkaert, Department of Economics, K.U. Leuven Download

12:00 – 13:00    Lunch (at the Aula)

Afternoon session 13:00 – 17:30
13:00 - 14:30 European perspective - Parallel sessions I

Strand I: Pricing and reimbursement policies in the light of the financial crisis

Chair: Kees de Joncheere, WHO Regional Office for Europe

  • Policy monitoring (Richard Laing, WHO Headquarters)
  • Pharmaceutical policies in response to the financial crisis (Sabine Vogler, WHO CC, GÖG) Download
  • Country examples:
    • Ireland (Kate Mulvenna, Health Service Executive) Download
    • Portugal (Miguel Gomes, INFARMED) Download
  • International experiences (Anita Wagner, Harvard Medical School and Harvard Pilgrim Health Care Institute, USA) Download

Strand II: The hospital setting as key sector - Interface management

Chair: Roberto Frontini, European Association of Hospital Pharmacists

  • Results and outcomes of a hospital survey - PHIS (Jan Mazag, State Institute for Drug Control, SUKL, SK) Download
  • The Swedish example (Rickard Malmström, Karolinska Hospital) Download
  • The Scottish example (Ken Paterson, Scottish Medicines Consortium) Download
  • The Norwegian example (Øyvind Melien, Norwegian Directorate of Health) Download

Strand III: How to interpret and compare pharmaceutical prices

Chairs: Claudia Habl, Bettina Schmickl, GÖG

  • Price comparison:
    • Price types and levels (Bettina Schmickl, GÖG) Download
    • Hospital price survey PHIS (Nina Zimmermann, GÖG) Download
  • European experiences with price comparisons:
    • Czech experiences (Lenka Vostalová, State Institute for Drug Control, SUKL, CZ) Download
    • Company perspecitve (Irma van den Arend, Ipsen Pharma SAS, France) Download

14:30 – 15:00    Coffee break (at the Aula)

15:00 - 16:30 European perspective - Parallel sessions II  

Strand I: Pharmaceutical pricing policies

Chair: Elizabeth Docteur, Elizabeth Docteur Consulting, USA

  • Comparison of prices (Valérie Paris, OECD) Download
  • External price referencing (Christine Leopold, GÖG) Download
  • Internal price referencing (Jaime Espin, Andalusian School of Public Health) Download

Strand II: Experiences with pharmaceutical profiles

Chair: Nina Zimmermann, GÖG

  • A common language (Sabine Vogler, WHO CC GÖG) Download
  • WHO experiences (Gilles Forte, WHO Headquarters) Download
  • Experiences from the Global Fund (Luca Li Bassi, The Global Fund to Fight AIDS, Tuberculosis and Malaria) Download

Strand III: Commercial aspects of rational use

Chair: Richard Laing, WHO Headquarters

  • Consumer view (Margaret Ewen, Health Action International) Download
  • Payers view (Ad R. Schuurman, Health Care Insurance Board (NL)) Download
  • Company view (Richard Bergström, EFPIA) Download
  • Pharmacist view (John Chave, Pharmaceutical Group of the European Union (PGEU), Belgium) Download

16:40 - 17:30 Key note presentation - Access to High Cost Medicines, examples from the Americas

Alexandre Lemgruber, The Pan American Health Organisation Download


Day 2: Friday 30th September 2011 (08:00 – 16:00)

Satellite session 08:00 – 08:45 (participation optional)

08:00 – 08:45    Meet editors of journals in the pharmaceutical field – question and answer session

Morning session 09:00 – 13:00

09:00 - 09:40 Key note Pricing and reimbursement of medicines – a European overview

Sabine Vogler, GÖG Download

09:40 - 11:00 Parallel poster sessions: Presentations of country examples of pharmaceutical systems

  • Western and Nordic countries
    Chair: Sveinbjörn Högnason, Icelandic Medicine Pricing and Remibursement Committee
    • Germany (Silke Baumann, Ministry of Health) Download
    • United Kingdom (David Kullmann, Department of Health) Download
    • Finland (Jaana Martikainen, The Social Insurance Institution) Download
  • Central and Eastern Europe
    Chair: Jan Mazag, SUKL Slovakia
    • Latvia (Janis Innus, Centre of Heath Economics) Download
    • Poland (Jakub Adamski, Ministry of Health) Download
    • Hungary (Judit Bidló, National Health Insurance Fund Administration) Download
  • Mediterranean countries (incl. FR)
    Chair: Miguel Gomes, INFARMED Portugal
    • France (Sophie Lopes, CNAMTS) Download
    • Greece (Lena Katsomiti, Greek Ministry of Health) Download
    • Spain (Piedad Ferre, Ministry of Health) Download
  • World perspective
    Chair: Joan Rovira, Barcelona University, Spain

10:35 – 11:00 Discussion on differences and similarities

11:00 - 11:30 Coffee break (at the Aula)

11:30 – 13:00     Parallel abstract presentations and poster session

  • Pricing and reimbursement of medicines
    Chairs: Jaime Espin, Andalusian School of Public Health (EASP), Christine Leopold, GÖG
    • Abstract # 85: Cost containment interventions introduced on the community drug schemes in Ireland - evaluation of expenditure trends using a national prescription claims database.
      (Cara Usher, National Centre for Pharmacoeconomics, Ireland) Download
    • Abstract # 91: Income Concentration and Price Differentiation in Low and Middle Income Pharmaceutical Markets (Eric L. Keuffel, Fox School of Business (Temple University), USA) Download
    • Abstract # 64: Performance of drug reimbursement systems: a comparison of the Austrian, Belgian, Dutch, French and Swedish systems (Margreet Franken, Institute for Health Policy and Management, Erasmus University Rotterdam, The Netherlands) Download
    • Poster presentations
      • Prices and affordability of medicines in Armenia (Margit Melikyan, Drug Utilisation Research Group Armenia) Download
      • Access to innovative anticancer drugs in the outpatient setting in Latvia (Marta Kipena, The Centre of Health Economics, Latvia) Download
      • Development of benchmarks to improve price negotiations of antiretroviral medicines for low and middle income countries (Veronika Wirtz, National Institute of Public Health, Mexico) Download
  • Hospital pharma - Interface management
    Chairs: Øyvind Melien, Norwegian Directorate of Health, Ján Mazag, SUKL - State Institute for Drug Control, Slovakia
    • Abstract # 67: Enhancing the utilisation of generic clopidogrel: a case history for future guidance? (Christoph Baumgaertel, AGES PharmMed, Austrian Medicines and Medical Devices Agency, and Kristina Garuoliené, National Health Insurance Fund under the Ministry of health of the Republic of Lithuania) Download
    • Abstract # 96: Influence of hospital choices of competitive drugs on the pharmaceutical consumption in the community (Adeline Gallini, University of Toulouse, France) Download
    • Abstract # 52: Do European rheumatoid arthritis patients have equal access to treatment with new medicines? (Joëlle M. Hoebert, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands) Download
    • Poster presentations
      • Characteristics of medicines management in Austrian hospitals (Elfriede Dolinar, Vienna General Hospital, Austria) Download
      • Access to high cost medicines: a systematic review of the literature (Philip Wahlster, University of Auckland, University of Greifswald, Germany) Download
  • Rational use of medicines
    Chairs: Aukje Mantel-Teeuwisse, Utrecht University, Anita Wagner, WHO CC Boston University
    • The need for generic policies as part of health reform (Richard Laing, WHO Headquarters) Download
    • Abstract # 56: Potential methods to enhance prescribing efficiency, implications for sustaining healthcare systems (Brian Godman - Division of Clinical Pharmacology, Karolinska Institutet, Sweden, Prescribing Research Group, Liverpool University, UK) Download
    • Health Care and Medicines Need and Access: Are there Gender Inequities? (Anita Wagner, Harvard Medical School and Harvard Pilgrim Health Care institute, USA) Download
    • Poster presentations
      • Report Cards on Prescribing Behavior: Assessing the Impacts of Public Disclosure on Antibiotic Prescribing Rate (Seemoon Choi, Department of Global Health and population, Harvard School of Public Health, USA) Download
      • High rate of self purchasing of oral antibiotics in Serbia: implications for future policies (Marija Kalaba, Republic Institute for Health Insurance, Republic of Serbia) Download
      • Essential to review health policy initiatives when comparing utilisation patterns across countries? (Brian Godman, Division of Clinical Pharmacology. Karolinska Institute, Sweden Presribing Research Group, Liverpool University, UK) Download

12:30 - 13:00    Poster walk
13:00 – 14:00    Lunch (at the Aula)

Afternoon session 14:00 – 16:00

14:00 – 14:45    Key note presentation - Pricing and reimbursement of medicines from global perspective

Andreas Seiter, World Bank Download

14:45 – 15:45    Panel discussion: The way forward - reflections and future directions

Chair: Sabine Vogler, GÖG

  • Valérie Paris, OECD
  • Anita Wagner, WHO CC Boston University/Harvard
  • Øyvind Melien, Norwegian Directorate of Health
  • Aarti Patel, Representative of Southern African Development Community
  • Karin Kadenbach, Member of the European Parliament, Austria
  • Hans Kluge, Director, Health Systems and Public Health, WHO Europe

15:45 – 16:00    Closing addresses

  • Karin Kadenbach, Member of the European Parliament, Austria
  • Sabine Vogler, WHO CC, Austrian Health Institute - GÖG